期刊文献+

0.1%糠酸莫米松在儿童特应性皮炎维持治疗中的临床分析 被引量:3

Clinical analysis of 0.1%mometasone furoate in the maintenance treatment of atopic dermatitis in children
下载PDF
导出
摘要 目的:观察0.1%糠酸莫米松乳膏在儿童特应性皮炎维持治疗中的临床效果。方法:将127例特应性皮炎患儿随机分为治疗组64例和对照组63例,两组患儿在相同治疗方案控制皮疹后,对照组患儿仅用润肤剂维持,治疗组患儿在润肤剂日常护理基础上继续予0.1%糠酸莫米松乳膏治疗,每周2次,分别在1~3周后观察治疗效果。结果:维持治疗后第1周治疗组复发2例,对照组4例,显效率分别为96.88%和93.65%,两组比较差异无统计学意义(P>0.05)。维持治疗后第2周治疗组复发3例,对照组10例,显效率分别为95.31%和84.13%,两组比较差异有统计学意义(P<0.05)。第3周治疗组复发5例,对照组18例,显效率分别为92.19%和71.43%,两组比较差异有统计学意义(P<0.01)。结论:在儿童特应性皮炎的治疗中,润肤剂和外用激素的使用能较快改善患儿症状,每周2次使用0.1%糠酸莫米松软膏维持治疗能有效减少特应性皮炎病情的反复,建议维持治疗3~4周。 Objective To observe the clinical effect of 0.1%mometasone furoate cream in the maintenance treatment of atopic dermatitis in children.Method 127 children with atopic dermatitis were randomly divided into two groups:the treatment group with 64 cases and the control group with 63 cases.After controlled the rash with the same treatment plan,the children in the treatment group were treated with 0.1%mometasone furoate cream twice a week in addition to the daily care of emollients,while the children in the control group were only maintained with emollients,and the therapeutic effects were observed after 1-3 weeks.Results There were 2 recurrent cases in the treatment group and 4 recurrent cases in the control group in the first week after maintenance treatment,the significant efficiency was 96.88%and 93.65%respectively,there was no statistical difference between the two groups(P>0.05);there were 3 recurrent cases in the treatment group and 10 recurrent cases in the control group in the second week after maintenance treatment,the significant efficiency was 95.31%and 84.13%respectively,there was statistical difference between the two groups(P<0.05);in the third week,5 recurrent cases recurred in the treatment group and 18 recurrent cases in the control group,with significant efficiency of 92.19%and 71.43%respectively(P<0.01).Conclusion In the treatment of children's atopic dermatitis,the use of emollients and external hormones can improve the symptoms of children quickly.The maintenance treatment of 0.1%mometasone furoate ointment twice a week can effectively reduce the recurrence of atopic dermatitis.It is recommended to maintain for 3-4 weeks.
作者 李巍 张婷 钱华 吴亚芬 胡翠 鲁慧 李纪兵 LI Wei;ZHANG Ting;QIAN Hua(Department of Dermatology,Children's Hospital Affiliated to Soochow University,Suzhou 215025,China)
出处 《吉林医学》 CAS 2021年第7期1574-1576,共3页 Jilin Medical Journal
基金 苏州市医疗卫生基础研究资助项目[项目编号:sys2018076]。
关键词 0.1%糠酸莫米松 特应性皮炎 维持治疗 儿童 0.1%mometasone furoate Atopic dermatitis Maintenance treatment Children
  • 相关文献

参考文献5

二级参考文献16

  • 1马琳.润肤剂及居家护理在特应性皮炎治疗中的作用[J].实用皮肤病学杂志,2009,0(1):69-70. 被引量:7
  • 2姜昱,周颖,张艳彩,伍晓云.0.1%糠酸莫米松霜治疗小儿湿疹56例的疗效观察[J].岭南皮肤性病科杂志,2000,7(4):31-31. 被引量:3
  • 3刘冰,伏瑾.婴儿湿疹的临床特征分析[J].中国麻风皮肤病杂志,2006,22(7):541-542. 被引量:49
  • 4Lucky AW, Grote GD, Williams JL, et al. Effect of desonide ointment 0.05% on the hypothalamic-pituitary-adrenal axis of childrenwith atopic dermatitis[J]. Cutis,1997,59(3): 151-153.
  • 5Lebrun-vlgnes B, Legrain V, Anoric J,et al. Comparative study of efficacy and effect on plasma cortisol levels of micronised desonide cream 0.1 P. 100 versus betamethasone dipropionate cream 0.05 P. 100 In the treatment of childhood atopic dermatitis [J]. Ann Dermatol Venereoh 2000, 127(6-7): 590-595.
  • 6Freeman S, Howard A, Foley P, et al. Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitis[J]. Australas J Dermatol,2002,43(3): 186-189.
  • 7Jorizzo J, Levy, Lucky A, et al .Multicenter trial for long-term safety and efficacy comparison of 0.05 % desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients [J]. J Am Acad Dermatol, 1995,33(1): 74-77.
  • 8Lucky AW,Grote GD,Williams JL,et al. Effect of desonideointment,0.05%,on the hypothalamic-pituitary-adrenal axis ofchildren with atopic deraiatitis[J]. Cutis,1997,59:151-153.
  • 9Mirshahpanah P,Ddcke WD,Merbold U,et al. Superior nuclearreceptor selectivity and therapeutic index of methylprednisoloneaceponate versus mometasone furoate[J],Exp Dermatol,2007,16:753-761.
  • 10Telofski LS,Morello AP 3rd,Mack Correa MC,et al. The infant skinbarrier:can we preserve,protect,and enhance the barrier,[J].Dermatol Res Pract,2012,198:789.

共引文献128

同被引文献100

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部